Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

DREAM raises pain relief hopes

15.01.2002


No dream: these mice feel little pain.
J. Penniger


Missing protein leaves mice impervious to pain

Researchers have a new lead for treating pain. A protein called DREAM appears to play a key role in how mice respond to heat, touch and inflammation1.

Mice lacking DREAM seem oblivious to all types of pain, find Josef Penninger and his colleagues at The AMGEN Institute, Toronto, Canada. The animals can bear acute pain - the kind caused for example by heat, pressure, or injections as well as chronic inflammatory pain - that which arthritis patients suffer. They seem otherwise normal.



DREAM was first identified in 1999, when it was known by three different names and had three different proposed functions in biological systems. "It was very unpredictable what DREAM would be doing physiologically," says Penninger.

The protein’s full name is Downstream Regulatory Element Antagonistic Modulator. Low DREAM levels are accompanied by high levels of dynorphin in the mice’s spinal cords. This morphine-like substance is believed to alleviate the animals experience of pain. "It’s exciting because it looks to be so specific," says Penninger.

While the results suggest altering DREAM function might be a way to change pain perception, practical applications are a long way off. "This is a major mechanistic insight," says John Wood who studies pain receptors at University College in London - but whether or not DREAM acts in a similar way in humans remains to be seen, he cautions.

Current estimates suggest that one in five people worldwide live with chronic pain from cancer and other debilitating diseases. Treatments with fewer side effects than existing analgesics have long been a goal for researchers.

References

  1. Cheng, H.-Y. M. et al. DREAM is a critical transcriptional repressor for pain modulation. Cell, 108, 31 - 43, (2002).


VIRGINIA GEWIN | © Nature News Service
Further information:
http://www.nature.com/nsu/020114/020114-1.html

More articles from Health and Medicine:

nachricht Finnish research group discovers a new immune system regulator
23.02.2018 | University of Turku

nachricht Minimising risks of transplants
22.02.2018 | Friedrich-Alexander-Universität Erlangen-Nürnberg

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Attoseconds break into atomic interior

A newly developed laser technology has enabled physicists in the Laboratory for Attosecond Physics (jointly run by LMU Munich and the Max Planck Institute of Quantum Optics) to generate attosecond bursts of high-energy photons of unprecedented intensity. This has made it possible to observe the interaction of multiple photons in a single such pulse with electrons in the inner orbital shell of an atom.

In order to observe the ultrafast electron motion in the inner shells of atoms with short light pulses, the pulses must not only be ultrashort, but very...

Im Focus: Good vibrations feel the force

A group of researchers led by Andrea Cavalleri at the Max Planck Institute for Structure and Dynamics of Matter (MPSD) in Hamburg has demonstrated a new method enabling precise measurements of the interatomic forces that hold crystalline solids together. The paper Probing the Interatomic Potential of Solids by Strong-Field Nonlinear Phononics, published online in Nature, explains how a terahertz-frequency laser pulse can drive very large deformations of the crystal.

By measuring the highly unusual atomic trajectories under extreme electromagnetic transients, the MPSD group could reconstruct how rigid the atomic bonds are...

Im Focus: Developing reliable quantum computers

International research team makes important step on the path to solving certification problems

Quantum computers may one day solve algorithmic problems which even the biggest supercomputers today can’t manage. But how do you test a quantum computer to...

Im Focus: In best circles: First integrated circuit from self-assembled polymer

For the first time, a team of researchers at the Max-Planck Institute (MPI) for Polymer Research in Mainz, Germany, has succeeded in making an integrated circuit (IC) from just a monolayer of a semiconducting polymer via a bottom-up, self-assembly approach.

In the self-assembly process, the semiconducting polymer arranges itself into an ordered monolayer in a transistor. The transistors are binary switches used...

Im Focus: Demonstration of a single molecule piezoelectric effect

Breakthrough provides a new concept of the design of molecular motors, sensors and electricity generators at nanoscale

Researchers from the Institute of Organic Chemistry and Biochemistry of the CAS (IOCB Prague), Institute of Physics of the CAS (IP CAS) and Palacký University...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

2nd International Conference on High Temperature Shape Memory Alloys (HTSMAs)

15.02.2018 | Event News

Aachen DC Grid Summit 2018

13.02.2018 | Event News

How Global Climate Policy Can Learn from the Energy Transition

12.02.2018 | Event News

 
Latest News

Basque researchers turn light upside down

23.02.2018 | Physics and Astronomy

Finnish research group discovers a new immune system regulator

23.02.2018 | Health and Medicine

Attoseconds break into atomic interior

23.02.2018 | Physics and Astronomy

VideoLinks
Science & Research
Overview of more VideoLinks >>>